Literature DB >> 2721252

Predictors of objective level of daytime sleepiness in patients with sleep-related breathing disorders.

T Roehrs1, F Zorick, R Wittig, W Conway, T Roth.   

Abstract

Excessive daytime sleepiness, the most prevalent symptom associated with the OSAS, is hypothesized to result from either fragmentation of sleep or hypoxemia during sleep. Measures of nocturnal sleep, respiration during sleep, and daytime sleepiness in 466 patients with apnea were collected to evaluate these two hypotheses. The various parameters were submitted to correlation and multiple regression analyses to predict daytime sleepiness as measured by the MSLT. The RAI, which measures the number of arousals from sleep associated with respiratory disturbances (best fragmentation correlation), produced a higher correlation with MSLT scores than did TMES (best hypoxemia correlation); however, the measures were highly intercorrelated, and multiple regression analyses to determine which parameters independently predicted MSLT showed the single best predictor to be the RAI. Additional independent variance in MSLT score was explained by TST and PSG1. Measures of hypoxemia provided little or no independent predictive information. These data support the hypothesis that sleep fragmentation is an important determinant of daytime sleepiness in patients with apnea.

Entities:  

Mesh:

Year:  1989        PMID: 2721252     DOI: 10.1378/chest.95.6.1202

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  28 in total

1.  Mortality in Obstructive Sleep Apnea: Association with Impaired Wakefulness.

Authors:  J. Steven Poceta; Daniel I. Loube; Erin L. Kellgren; Kaysha Bizik; Merrill M. Mitler
Journal:  Sleep Breath       Date:  1999       Impact factor: 2.816

2.  Induction of sleep apnoea with negative pressure ventilation in patients with chronic obstructive lung disease.

Authors:  R D Levy; M G Cosio; L Gibbons; P T Macklem; J G Martin
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

Review 3.  Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome.

Authors:  H M Engleman; N J Douglas
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

Review 4.  Sleep and obesity: a focus on animal models.

Authors:  Vijayakumar Mavanji; Charles J Billington; Catherine M Kotz; Jennifer A Teske
Journal:  Neurosci Biobehav Rev       Date:  2012-01-16       Impact factor: 8.989

5.  Pulse wave amplitude drops during sleep are reliable surrogate markers of changes in cortical activity.

Authors:  Alexandre Delessert; Fabrice Espa; Andrea Rossetti; Gilles Lavigne; Mehdi Tafti; Raphael Heinzer
Journal:  Sleep       Date:  2010-12       Impact factor: 5.849

6.  Neural Respiratory Drive and Arousal in Patients with Obstructive Sleep Apnea Hypopnea.

Authors:  Si-Chang Xiao; Bai-Ting He; Joerg Steier; John Moxham; Michael I Polkey; Yuan-Ming Luo
Journal:  Sleep       Date:  2015-06-01       Impact factor: 5.849

7.  Proteomic biomarkers of sleep apnea.

Authors:  Aditya Ambati; Yo-El Ju; Ling Lin; Alexander N Olesen; Henriette Koch; Julien Jacques Hedou; Eileen B Leary; Vicente Peris Sempere; Emmanuel Mignot; Shahrad Taheri
Journal:  Sleep       Date:  2020-11-12       Impact factor: 5.849

Review 8.  Obstructive Sleep Apnea and Its Treatment in Aging: Effects on Alzheimer's disease Biomarkers, Cognition, Brain Structure and Neurophysiology.

Authors:  Anna E Mullins; Korey Kam; Ankit Parekh; Omonigho M Bubu; Ricardo S Osorio; Andrew W Varga
Journal:  Neurobiol Dis       Date:  2020-08-27       Impact factor: 5.996

9.  Identification of sleep disruption and sleep disordered breathing from the systolic blood pressure profile.

Authors:  R J Davies; K Vardi-Visy; M Clarke; J R Stradling
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

10.  Lack of regular exercise, depression, and degree of apnea are predictors of excessive daytime sleepiness in patients with sleep apnea: sex differences.

Authors:  Maria Basta; Hung-Mo Lin; Slobodanka Pejovic; Alexios Sarrigiannidis; Edward Bixler; Alexandros N Vgontzas
Journal:  J Clin Sleep Med       Date:  2008-02-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.